tiprankstipranks
Advertisement
Advertisement

NRSN Stock Latest News

NeuroSense Secures South Korean Patent for ALS Drug Candidate PrimeC
Company AnnouncementsNeuroSense Secures South Korean Patent for ALS Drug Candidate PrimeC
7d ago
6K
NRSN
NeuroSense granted South Korean patent covering PrimeC composition for ALS
PremiumThe Fly
NeuroSense granted South Korean patent covering PrimeC composition for ALS
7d ago
NRSN
NeuroSense Therapeutics Wins Key Japanese Patent for ALS Drug PrimeC
PremiumCompany Announcements
NeuroSense Therapeutics Wins Key Japanese Patent for ALS Drug PrimeC
8d ago
6K
NRSN
NeuroSense granted Japanese patent for PrimeC novel composition in ALS
PremiumThe Fly
NeuroSense granted Japanese patent for PrimeC novel composition in ALS
9d ago
NRSN
NeuroSense Therapeutics Advances Canadian Regulatory Talks on ALS Drug PrimeC
PremiumCompany Announcements
NeuroSense Therapeutics Advances Canadian Regulatory Talks on ALS Drug PrimeC
10d ago
6K
NRSN
NeuroSense Secures Insider-Led $600,000 PIPE at Premium Share Price
PremiumCompany AnnouncementsNeuroSense Secures Insider-Led $600,000 PIPE at Premium Share Price
2M ago
6K
NRSN
NeuroSense announces departure of Chief Medical Officer
Premium
The Fly
NeuroSense announces departure of Chief Medical Officer
2M ago
NRSN
NeuroSense Therapeutics Transitions Chief Medical Officer to Advisory Role Ahead of Key PrimeC Milestones
Premium
Company Announcements
NeuroSense Therapeutics Transitions Chief Medical Officer to Advisory Role Ahead of Key PrimeC Milestones
2M ago
6K
NRSN
NeuroSense Wins Long-Term Brazilian Patent Protection for ALS Drug PrimeC
PremiumCompany Announcements
NeuroSense Wins Long-Term Brazilian Patent Protection for ALS Drug PrimeC
2M ago
6K
NRSN
NeuroSense granted Brazilian patent covering PrimeC composition
PremiumThe Fly
NeuroSense granted Brazilian patent covering PrimeC composition
2M ago
NRSN
NeuroSense Therapeutics Faces Nasdaq Deficiency Notices but Retains Listing Status
PremiumCompany Announcements
NeuroSense Therapeutics Faces Nasdaq Deficiency Notices but Retains Listing Status
3M ago
6K
NRSN
NeuroSense Therapeutics Posts 2025 Results as PrimeC Advances Toward Phase 3 ALS Trial
PremiumCompany Announcements
NeuroSense Therapeutics Posts 2025 Results as PrimeC Advances Toward Phase 3 ALS Trial
3M ago
6K
NRSN
NeuroSense Reschedules Health Canada Meeting as PrimeC Data Package Strengthens
PremiumCompany AnnouncementsNeuroSense Reschedules Health Canada Meeting as PrimeC Data Package Strengthens
3M ago
6K
NRSN
Neurosense Therapeutics Ltd. (NRSN) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Neurosense Therapeutics Ltd. (NRSN) Q4 Earnings Cheat Sheet
3M ago
NRSN
NeuroSense’s ALS Drug PrimeC Shows Strong Phase 2b Results in JAMA Neurology
Premium
Company Announcements
NeuroSense’s ALS Drug PrimeC Shows Strong Phase 2b Results in JAMA Neurology
3M ago
6K
NRSN
NeuroSense Shareholders Approve Increase in Registered Share Capital
PremiumCompany Announcements
NeuroSense Shareholders Approve Increase in Registered Share Capital
3M ago
6K
NRSN
NeuroSense initiated with a Buy at Roth Capital
PremiumThe Fly
NeuroSense initiated with a Buy at Roth Capital
3M ago
NRSN
NeuroSense Reports 65% Lower Mortality Risk and 14-Month Survival Gain for PrimeC in ALS Trial
PremiumCompany Announcements
NeuroSense Reports 65% Lower Mortality Risk and 14-Month Survival Gain for PrimeC in ALS Trial
4M ago
6K
NRSN
NeuroSense reports additional long-term survival data from PARADIGM 2b trial
PremiumThe Fly
NeuroSense reports additional long-term survival data from PARADIGM 2b trial
4M ago
NRSN
NeuroSense Therapeutics Calls March 10, 2026 Special Meeting to Approve Share Capital Increase
PremiumCompany AnnouncementsNeuroSense Therapeutics Calls March 10, 2026 Special Meeting to Approve Share Capital Increase
4M ago
6K
NRSN
NeuroSense Wins Australian Patent to Extend PrimeC IP Protection Through 2042
Premium
Company Announcements
NeuroSense Wins Australian Patent to Extend PrimeC IP Protection Through 2042
4M ago
6K
NRSN
NeuroSense granted Australian patent covering PrimeC composition
Premium
The Fly
NeuroSense granted Australian patent covering PrimeC composition
4M ago
NRSN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >